Patent ID: 11931414
Assignee: SEAGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 18:
19. The Ligand Drug Conjugate compound of claim 1, wherein the compound is represented by the structure of:, or a salt thereof, wherein Ab is an antibody Ligand Unit from an intact antibody or antigen-binding fragment of an antibody or the antigen-binding fragment of the antibody; S is a sulfur atom from the antibody; and subscript p′ is 8, or
wherein the compound is represented by the structure of:, or a salt thereof, wherein Ab is an antibody Ligand Unit from an intact antibody or antigen-binding fragment of an antibody or the antigen-binding fragment of the antibody; S is a sulfur atom from the antibody; and subscript p′ is 8.